Centogene NV
NASDAQ:CNTG
Centogene NV
Other Operating Expenses
Centogene NV
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Centogene NV
NASDAQ:CNTG
|
Other Operating Expenses
€3.7m
|
CAGR 3-Years
51%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Other Operating Expenses
€23.6m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Other Operating Expenses
-€2m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-24%
|
|
Immatics NV
NASDAQ:IMTX
|
Other Operating Expenses
€1.1m
|
CAGR 3-Years
56%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Other Operating Expenses
-€12.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Formycon AG
XETRA:FYB
|
Other Operating Expenses
€2.5m
|
CAGR 3-Years
360%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's Other Operating Expenses?
Other Operating Expenses
3.7m
EUR
Based on the financial report for Dec 31, 2022, Centogene NV's Other Operating Expenses amounts to 3.7m EUR.
What is Centogene NV's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
49%
Over the last year, the Other Operating Expenses growth was 29%. The average annual Other Operating Expenses growth rates for Centogene NV have been 51% over the past three years , 49% over the past five years .